All the FDA has to do is wink an eye to accelerated approval, even if it wants to see the Feb 2018 final safety of the crossover study, and we/VCEL are golden, as you say
I totally agree with you.
I would like to see some insider buying kicking in, why wouldn't they or are they in quiet periods because of this B meeting with FDA ?